Clinical trial
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive…
NCT00338286 · Janssen Research & Development, LLC, Industry · Completed
Key facts
| NCT number | NCT00338286 |
|---|---|
| Title | A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy |
| Official title | A Randomized, Open-label, Multicenter, Phase 3 Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy |
| Lead sponsor | Janssen Research & Development, LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer, Neoplasm Metastasis |
| Intervention type | Drug, Other |
| Interventions | Standard supportive care (packed RBC transfusion), epoetin alfa + packed RBC transfusion |
| Enrollment | 2,098 |
| Start date | Mar 2, 2006 |
| Primary completion | Jul 7, 2014 |
| Completion | Jan 31, 2017 |
| First posted | Jun 20, 2006 |
| Last update posted | Mar 19, 2018 |
| Countries | Argentina, Brazil, Bulgaria, Chile, Colombia, Ecuador, Georgia, Hong Kong, India, Indonesia, Malaysia, Mexico and 9 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: